World news, news around town, tech update 3
Ad
Thursday, 8 November 2018
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment